NEWS

Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. With Druggability Technologies

DDF 2019 - Berlin

Meet us at DDF in Berlin (booth #31) to discuss your formulation development, drug product manufacturing or phase I clinical study requirements you may have.

When: 11-13 March, 2019

Where: Berlin, Germany

If you would like to meet us there, please email info@quotientsciences.com

Nikki Whitfield will be presenting: How do I quickly develop first-in-human (FIH) dosage forms and bridge to drug products for proof-of-concept (POC)?

This presentation will cover:

  • Choosing the appropriate dosage form for first-in-human/Phase I trials – fit for purpose, fit for phase?
  • Compounding or GMP manufacturing – how to balance cost, time and dose flexibility?
  • Challenges with poorly soluble molecules in early development – what technologies can we deploy?
  • Bridging to robust and scalable Phase II drug products – how to avoid losing time in development?
  • Highly flexible and adaptive clinical manufacturing strategies for patient trials – how can real-time manufacturing be used?

Day: 11 March, 2019

Time: 2:30PM to 3:05PM

Ask us a question